Related Experiment Video
Updated: Jun 3, 2025
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Patient Factors Influence Minimal Clinically Important Difference for the SNOT-22 in Medically Treated Chronic
Mohamed A Aboueisha1,2, Felix E Fernández-Penny1,3, Jacob Hodges1
1Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA.
Background:
The present study explores the effect of sociodemographics and comorbidities on the calculated minimal clinically important difference (MCID) for 22-item Sinonasal Outcome Test (SNOT-22) scores in patients with medically treated chronic rhinosinusitis (CRS). The importance of delineating a threshold to indicate clinically meaningful changes perceived by a patient is well acknowledged, yet the influence of patient-specific factors on MCID has not been fully elucidated.
Methods:
Patients with CRS (n = 221) presenting to a tertiary care practice reported their change in disease burden with anchor questions following CRS-directed medical treatment. Baseline sociodemographics, pertinent history, and comorbid conditions, as well as pre- and post-treatment SNOT-22 scores were also collected. Adjusted logistic regression was utilized to determine the factors influencing MCID.
Results:
Among the 221 patients, 43.9% (n = 97) reported improvement following medical treatment. Gender, education level, depression, and migraine were identified as significant factors influencing perceived improvement. Our predictive model, incorporating these variables, achieved an area under the receiver operating characteristic curve of 0.818 (95% confidence interval [CI] = 0.762, 0.875), with a sensitivity of 74.4% and specificity of 77.9%. Changes in SNOT-22 scores were not strongly associated with perceived improvement in patients with depression (odds ratio [OR] = 1.06; 95% CI = 0.98, 1.14; p = 0.140). Conversely, patients with migraines perceived more pronounced improvements or deteriorations at the extremes of SNOT-22 score changes (OR = 0.84; 95% CI = 0.76, 0.93; p = 0.001).
Conclusion:
Our findings underscore the substantial impact of patient-specific sociodemographics and comorbidities on the calculation of MCID values for the SNOT-22. This study advances our understanding of variability in MCID and demonstrates the complex milieu of factors affecting patients' perceived clinical outcomes.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:20Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
01:30Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
01:26Tonsillitis II: Management